| Khadija Najid, DO | |
|
1600 Haddon Ave Fl 3, Camden, NJ 08103-3101 | |
| (856) 757-3500 | |
| Not Available |
| Full Name | Khadija Najid |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1600 Haddon Ave Fl 3, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164715959 | NPI | - | NPPES |
| 0278149 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 25MB08976500 (New Jersey) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 25MB08976500 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services. The Centers for Medicare and Medicaid Services directly cut imaging reimbursement every year since 2007. This, along with 12 Medicare imaging cuts in the last six years due to legislation, increasingly threatens patient care.
Qioptiq, an Excelitas Technologies Company and global technology leader in delivering innovative optical and photonic solutions, will present its new wavelength pairing for the popular iFLEX-Gemini Dual-Wavelength Laser Series with new 488/647nm wavelengths at SPIE Photonics West.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
› Verified 9 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services. The Centers for Medicare and Medicaid Services directly cut imaging reimbursement every year since 2007. This, along with 12 Medicare imaging cuts in the last six years due to legislation, increasingly threatens patient care.
Qioptiq, an Excelitas Technologies Company and global technology leader in delivering innovative optical and photonic solutions, will present its new wavelength pairing for the popular iFLEX-Gemini Dual-Wavelength Laser Series with new 488/647nm wavelengths at SPIE Photonics West.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
› Verified 9 days ago
| Entity Name | The Osborn Family Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528444254 PECOS PAC ID: 1658681184 Enrollment ID: O20151112000931 |
News Archive
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services. The Centers for Medicare and Medicaid Services directly cut imaging reimbursement every year since 2007. This, along with 12 Medicare imaging cuts in the last six years due to legislation, increasingly threatens patient care.
Qioptiq, an Excelitas Technologies Company and global technology leader in delivering innovative optical and photonic solutions, will present its new wavelength pairing for the popular iFLEX-Gemini Dual-Wavelength Laser Series with new 488/647nm wavelengths at SPIE Photonics West.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Khadija Najid, DO 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Khadija Najid, DO 1600 Haddon Ave Fl 3, Camden, NJ 08103-3101 Ph: (856) 757-3500 |
News Archive
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services. The Centers for Medicare and Medicaid Services directly cut imaging reimbursement every year since 2007. This, along with 12 Medicare imaging cuts in the last six years due to legislation, increasingly threatens patient care.
Qioptiq, an Excelitas Technologies Company and global technology leader in delivering innovative optical and photonic solutions, will present its new wavelength pairing for the popular iFLEX-Gemini Dual-Wavelength Laser Series with new 488/647nm wavelengths at SPIE Photonics West.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
› Verified 9 days ago
Dr. Eric Kfir Yahav, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 817 Federal Street, Camcare Health Corporation, Camden, NJ 08103 Phone: 856-541-2229 | |
Dr. Ume Farwa, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 817 Federal St, Camden, NJ 08103 Phone: 856-583-2400 | |
Dr. Ankita Kulkarni, M.B.B.S Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz Rm 628, Camden, NJ 08103 Phone: 856-342-2491 | |
Christina S Chu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Cooper Plz, Camden, NJ 08103 Phone: 855-632-2667 Fax: 856-735-6455 | |
Amanda Malik, MD MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz Rm 200, Camden, NJ 08103 Phone: 856-342-2959 | |
Dr. Jennifer E. Hummel, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz # D424, Camden, NJ 08103 Phone: 856-968-7396 | |
Dr. Michael J Deary, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1601 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3700 Fax: 856-365-7972 |